Functional evaluation of five BRCA2 unclassified variants identified in a Sri Lankan cohort with inherited cancer syndromes using a mouse embryonic stem cell-based assay
Open Access
- 10 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research
- Vol. 22 (1), 1-5
- https://doi.org/10.1186/s13058-020-01272-z
Abstract
Next-generation sequencing of Sri Lankan families with inherited cancer syndromes resulted in the identification of five BRCA2 variants of unknown clinical significance. Interpreting such variants poses significant challenges for both clinicians and patients. Using a mouse embryonic stem cell-based functional assay, we found I785V, N830D, and K2077N to be functionally indistinguishable from wild-type BRCA2. Specific but mild sensitivity to olaparib and reduction in homologous recombination (HR) efficiency suggest partial loss of function of the A262T variant. This variant is located in the N-terminal DNA binding domain of BRCA2 that can facilitate HR by binding to dsDNA/ssDNA junctions. P3039P is clearly pathogenic because of premature protein truncation caused by exon 23 skipping. These findings highlight the value of mouse embryonic stem cell-based assays for determining the functional significance of variants of unknown clinical significance and provide valuable information regarding risk estimation and genetic counseling of families carrying these BRCA2 variants.Funding Information
- National Cancer Institute (Intramural Research Program)
This publication has 14 references indexed in Scilit:
- Genetics and genomic medicine in Sri LankaMolecular Genetics & Genomic Medicine, 2019
- Implementation of genomic medicine in Sri Lanka: Initial experience and challengesApplied & Translational Genomics, 2016
- ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencingGenetics in Medicine, 2013
- Comparative In Vitro and In Silico Analyses of Variants in Splicing Regions of BRCA1 and BRCA2 Genes and Characterization of Novel Pathogenic MutationsPLOS ONE, 2013
- Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer familiesInternational Journal of Oncology, 2012
- Comprehensive splicing functional analysis of DNA variants of the BRCA2 gene by hybrid minigenesBreast Cancer Research, 2012
- Mouse embryonic stem cell–based functional assay to evaluate mutations in BRCA2Nature Medicine, 2008
- Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, CanadaJNCI Journal of the National Cancer Institute, 2006
- RNA-based analysis of BRCA1 and BRCA2 gene alterationsCancer Genetics and Cytogenetics, 2006
- Screening for BRCA2 mutations in 81 Dutch breast–ovarian cancer familiesBritish Journal of Cancer, 2000